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Abstract: Magnesium plays a pivotal role in energy metabolism and in the control of cell growth.
While magnesium deprivation clearly shapes the behavior of normal and neoplastic cells, little is
known on the role of this element in cell differentiation. Here we show that magnesium deficiency
increases the transcription of multipotency markers and tissue-specific transcription factors in human
adipose-derived mesenchymal stem cells exposed to a mixture of natural molecules, i.e., hyaluronic,
butyric and retinoid acids, which tunes differentiation. We also demonstrate that magnesium
deficiency accelerates the osteogenic differentiation of human bone marrow-derived mesenchymal
stem cells. We argue that magnesium deprivation generates a stressful condition that modulates
stem cell plasticity and differentiation potential. These studies indicate that it is possible to remodel
transcription in mesenchymal stem cells by lowering extracellular magnesium without the need for
genetic manipulation, thus offering new hints for regenerative medicine applications.
Keywords: magnesium; human bone marrow mesenchymal stem cells; human adipose-derived
mesenchymal stem cells; osteogenic differentiation; transcriptional remodeling
1. Introduction
Magnesium (Mg) is essential for life and health, since it is implicated in all metabolic and
biochemical processes in the cell, including energy metabolism, DNA duplication, RNA transcription,
protein synthesis and redox reactions [1]. Mg also acts as an intracellular second messenger and as
a natural calcium antagonist [2,3]. A large amount of data shows a compelling role for Mg in the
maintenance of cellular physiology and in the control of cell proliferation [3], because Mg contributes
to the regulation of the cell cycle. Initially, Mg is mandatory for the activation of the kinases that
transduce the mitotic signal from plasma membrane receptors to the nucleus. Next, Mg is required to
sustain protein synthesis and to replicate DNA [3]. Accordingly, intracellular Mg increases fractionally
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in the G1 and S phase of the cell cycle. In the late stages, Mg has a role in the assembly of the mitotic
spindle [4]. On these bases, it is not surprising that low concentrations of extracellular Mg inhibit the
growth of cultured mammalian cells by decreasing the number of cells in the S phase and promoting
their accumulation mainly in the G0/G1 and also in G2/M phases of the cell cycle [1]. In Mg-deficient
conditions, growth inhibition also results from aberrant mitochondrial function with the consequent
loss of control over cellular energy turnover [5], hence generating energetic stress [6]. In agreement
with these findings, chemical or genetic inhibition of Mg transporters and channels constrains cell
growth, and this can be overridden by Mg supplementation [7]. While the link between Mg and cell
growth has been deeply investigated, comparatively little is known on the role of this element in cell
differentiation. A few studies suggest that extracellular Mg differently affects cell differentiation [7–10].
Recently, intriguing results were obtained in human embryonic stem cells [11]. Mg withdrawal induced
by mesendogen, an inhibitor of TRPM6/TRPM7 (the principal ion channels responsible for cellular
Mg import), promotes mesoderm and definitive endoderm differentiation [11].
It is emerging that different kinds of cellular stress enhance or modulate cell differentiation [12–15].
The concept that stress has a fundamental role in cell plasticity and cell reprogramming has been
recently reviewed [16]. It is feasible to hypothesize that stress primes the cells to a phase of readiness
to cope with a hostile or simply unusual environment.
Since (i) Mg deprivation is associated with energetic and oxidative stress in several cell types and
tissues [6,17,18], and (ii) redox regulation is implicated in various differentiation and de-differentiation
processes [14], we reasoned that Mg withdrawal might reprogram and modulate the differentiation
of mesenchymal stem cells. In this light, a proper tuning of Mg homeostasis can be viewed as
a novel tool to chemically manipulate stem cell fate without the need of viral vector mediated
gene transfer technologies or the use of cumbersome chemistry for the development of synthetic
differentiating agents.
In this study, the rationale was to investigate the effects of the stress generated by Mg
deprivation both on cell reprogramming and terminal cell differentiation. These are distinct and
complementary processes, which require the use of different experimental models and different
protocols. To accomplish this task, we have selected two different mesenchymal stem cell models,
i.e., adipose-derived mesenchymal stem cells (AD-MSCs) and bone marrow mesenchymal stem cells
(BM-MSCs), whose reprogramming and differentiation protocols are well established and standardized.
Indeed, while both cell types are osteogenic, BM-MSCs have been extensively used to investigate
osteoblastic differentiation and seem to perform better than AD-MSCs [19], while AD-MSCs have been
widely used as multilineage cell model, partly thanks to the minimally invasive harvest of the adipose
tissue and the ease of obtaining large amounts of cells [20–22].
AD-MSCs were cultured in normal or Mg-deficient media in the presence of a reprogramming
medium composed of a mixture of hyaluronic, butyric and retinoic acids (hereafter referred
to as RM) [23,24], a cocktail which tunes differentiation potential. Indeed, previous work has
demonstrated that this mixture commits human amniotic fluid stem cells toward cardiac and
angiogenic phenotype [24]. We then assessed the expression of the multipotency gene Nanog
Homeobox (NANOG) and tissue-restricted transcription factors, such as GATA Binding Protein 4
(GATA-4), NKX2 Homeobox 5 (NKX-2.5), Hepatocyte Growth Factor (HGF), Kinase Insert Domain
Receptor (KDR), Neurogenin (NEUROG). GATA-4 and NKX-2.5 are two key regulators of cardiogenic
commitment. In particular, NKX-2.5 is the earliest marker of the cardiac lineage [25]. HGF and KDR
are involved in the orchestration of vasculogenesis and proper capillary formation [26,27]. NEUROG
is a marker of neurogenic commitment [28], while NANOG is involved in the maintenance of stem cell
pluripotency [29,30].
We also examined the impact of Mg deprivation on the osteogenic differentiation of BM-MSCs
treated with vitamin D and glycerolphosphate [31]. We evaluated the expression of transcription
factors required for osteogenesis, as well as the deposition of extracellular calcium, since the formation
of a mineralized extracellular matrix is a hallmark of osteogenic differentiation.
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2. Results
2.1. Mg and the Transcriptional Remodeling of Adipose-Derived Mesenchymal Stem Cells (AD-MSCs)
AD-MSCs were cultured for 5 and 10 days in normal or Mg-deficient medium in the absence or in
the presence of a cocktail containing hyaluronic, butyric and retinoic acids (reprogramming medium,
RM) [23,24]. We examined gene expression of a panel of markers representing the multilineage potential
of these cells, such as GATA-4, NKX-2.5, HGF, KDR, NEUROG and NANOG. By Real-time PCR we
found that the expression of the aforementioned markers is significantly enhanced in RM-treated cells
under Mg-deficiency compared to RM-treated controls after 5 and 10 days from the beginning of the
experiment (Figure 1A).
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Figure 1. Effect of g ithdra al and re-supple entation on gene expression in adipose-derived
esenchy al ste cells (AD- SCs). (A) Expression of multilineage markers in AD-MSCs treated
in reprogra ming medium (RM 1.0 m Mg, black bar), or in Mg-deficient medium (RM 0.1 mM
Mg, white bar). From the left: G TA-4, NKX-2.5, NEUROG, NANOG, HGF, KDR. All the values ere
nor alized ith respect to their untreated controls. * p < 0.05, ** p < 0.01, *** p < 0.001. ( ) Expression
f TA-4, NKX-2.5, HGF, NEUROG, NANOG and KDR in cells cultured in complete RM (black bar) or
in Mg-deficient medium (white bar) for 10 days. Some samples were kept in g-deficient e i
f r a then su plemented with 1 m Mg for additional 5 days (grey bar). All the values
we e normalized with respect to thei untreated controls (i.e., without the reprogramming cocktail).
The re ults ar th mean of three xperiments carried out in triplicate. ** p < 0.01, *** p < 0.001.
To further dissect the involvement of Mg in the modulation of gene expression in AD-MSCs,
we examined the levels of these transcripts in RM-treated cells cultured in Mg-deficient medium for
5 days and then supplemented with Mg to reach the physiologic concentration of 1 mM. We found that
the Mg supplementation decreased the expression of all the genes to the same level of samples cultured
in complete medium (Figure 1B), thus demonstrating that the enhancement of the reprogramming
markers induced by Mg deficiency is fully reversible. Based on these observations, the transcriptional
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remodeling of Mg-deprived cells cultured in RM can be viewed as a response to the dramatic,
non-physiological external trigger represented by Mg deficiency.
The study of the mechanisms that govern self-renewal and lineage specification are still poorly
explored. Because cell cycle position seems to influence the response to differentiation agents [32],
we determined cell cycle profile by flow cytometry in control and stimulated AD-MSCs cultured in
Mg-deficient media for 5 and 10 days. Interestingly, we observed a remarkable accumulation of cells in
the G2/M phase in treated cells at all times tested (Figure 2A, lower table). Moreover, both control
and stimulated Mg-deprived AD-MSCs showed the same intracellular total Mg content (Figure 2B).
This suggests that the block of the cell cycle at G2/M phase is induced by the RM rather than Mg
deprivation (Figure 2A, lower table), since RM-exposed cells showed an accumulation in the G2/M
phase of the cell cycle also in complete medium (Figure 2A, upper table).
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calcified matrix is comparable in control BM-MSCs and in cells deprived of Mg for 5 days and then
restored to physiologic concentration. We argue that, once the early genetic program for differentiation
is activated in Mg-deficient cells, the return to 1 mM restores the normal physiologic response to the
osteogenic cocktail.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  5 of 13 
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Figure 3. Effect of Mg withdrawal and re-supplementation in differentiating bone marrow mesenchymal
stem cells (BM-MSCs). (A) BM-MSCs were cultured in 1 mM Mg (middle panel) or in Mg-deprived
medium (left panel) and exposed to control medium (CM) or osteogenic medium (OM). BM-MSCs
were cultured in Mg-deficient medium for 5 days and in 1 mM Mg for the following 9 days. After
14 days we evaluated the deposition of calcium phosphate in the extracellular matrix by Alizarin Red S
staining. Photographs were taken at 10× magnification. (B) The absorbance of Alizarin Red S staining
was measured at 550 nm. ** p < 0.01. (C) BM-MSCs were cultured in 1 mM Mg or in g-deprived
medium and exposed to CM or OM for 2, 4 and 7 days. Real-time PCR was performed three times,
carried out in triplicate, on RNA extracted using primers designed on RUNX2 and Osterix (OSX)
sequence. All the values were normalized with respect to their controls cultured in CM. ** p < 0.01.
Next, we evaluated the expression of two early markers of osteogenic differentiation, i.e.,
RUNX2 and Osterix (OSX), transcription factors essential for osteoblast differentiation and bone
formation during embryonic development, but crucial also for postnatal bone growth and homeostasis.
In particular, since no ossification occurs in RUNX2−/− mice, RUNX2 is considered the master
regulator of osteogenesis, while OSX is necessary to activate the early stages of osteogenesis but
is not sufficient for complete differentiation. By Real-time PCR on samples collected at different
times after induction, we found that Mg deficiency sensitizes BM-MSCs to the osteogenic cocktail
(Figure 3C). Indeed, at day 4, the differentiation cocktail induced both RUNX2 and OSX more markedly
in Mg-deficient cells than in their controls in 1 mM Mg. Figure S4 shows that the induction of COL1A1,
essential for the progression of differentiation, and BGLAP, a non-collagenous component of bone
extracellular matrix, is greater in Mg-deficient BM-MSCs.
It is known that (i) culture in low extracellular Mg is linked to an increased generation of ROS in
many cell types [18]; and (ii) the generation of ROS is needed for osteogenic differentiation of BM-MSCs.
Accordingly, in BM-MSCs exposed to Mg-deficient medium, we reproducibly found a 30% increase
of ROS production, which was blocked by the synthetic antioxidant N-acetylcysteine (NAC, 1 mM)
(Figure 4A). On these bases, it is not surprising that NAC prevents the enhancement of BM-MSC
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differentiation by low extracellular Mg (Figure 4B–D). Indeed, in the presence of NAC, no significant
differences occurred in the expression of osteogenic markers and in extracellular calcium deposition in
BM-MSCs induced to differentiate in normal or Mg-deficient medium (Figure 4B–D).Int. J. ol. Sci. 2018, 19, x FOR PEER REVIEW  6 of 13 
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and retinoic acids toward multiple lineage, including neuronal, cardiac and vascular fates. 
Concomitant with the expression of lineage-restricted genes, Mg deficiency also enhances the 
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which regulate the maintenance of the pluripotent state in embryonic stem cells, are not [35]. Since 
Figure 4. Relationship between Mg withdrawal and reactive oxygen species (ROS) generation. (A) Bone
marrow mesenchymal stem cells (BM-MSCs) were cultured in 1 mM Mg or in Mg-deprived medium
and exposed to control medium (CM). The cells were then treated with N-acetylcysteine (NAC, 1 mM)
for 24 h. ROS generation was measured. Data are shown as the mean of three separate experiments
± standard deviation. ** p < 0.01, *** p < 0.001. (B) BM-MSCs were cultured in 1 mM Mg or in
Mg-deficient medium and exposed to CM or to osteogenic medium (OM). The cells were then treated
with NAC (1 mM) for 14 days. Alizarin Red S staining was performed, and photographs were
taken at 10×magnification. (C) The absorbance of Alizarin Red S staining was measured at 550 nm.
** p < 0.01. (D) BM-MSCs were cultured in 1 mM Mg or in Mg-deficient medium and exposed to CM or
OM. The cells were then treated with NAC for 4 days. Real-time PCR was performed three times in
triplicate on RNA extracted using primers designed on RUNX2 and OSX sequence. All the values were
normalized with respect to their controls cultured in CM. The results are the mean of three experiments
in triplicates. * p < 0.05.
3. Discussion
We demonstrate that both adipose- and bone marrow-derived mesenchymal stem cells are
sensitized to differentiation stimuli when cultured in low extracellular Mg. This effect is promptly
reversible after restoring the physiologic concentration of the cation, indicating that no permanent
modifications occur as a result of the deprivation of the cation in the time frame utilized in this study,
as previously shown in other cell types [34].
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Mg deficiency potentiates the commitment of AD-MSCs with a mixture of hyaluronic, butyric and
retinoic acids toward multiple lineage, including neuronal, cardiac and vascular fates. Concomitant
with the expression of lineage-restricted genes, Mg deficiency also enhances the expression of the
stemness-related gene NANOG after exposure to the reprogramming cocktail. It is reported that
NANOG is expressed in cultured mesenchymal stem cells, while SOX2 and OCT4, which regulate the
maintenance of the pluripotent state in embryonic stem cells, are not [35]. Since NANOG expression
(i) does not associate with the proliferative and differentiative potential of MSCs, and (ii) does not
pinpoint cells having stem or progenitor cell properties, NANOG seems to contribute to regulate cell
adaption to in vitro growth conditions [36]. We hypothesize that the induction of NANOG by Mg
deficiency has a role in maintaining the cells viable and ready to respond to specific stimuli. This is
a relevant issue, because low survival rates are the major obstacle to a broad clinical use of MSCs.
The mechanisms underlying the effect of Mg deficiency in implementing the response to the
reprogramming medium of AD-MSCs remain elusive. Initially, we reasoned that low Mg could
influence cell cycle position, which is known to affect the response to differentiation agents in MSCs [32].
Indeed, pluripotent stem cells are more responsive to specification clues in the G1 phase of the cell
cycle [32,37], while apigenin and nocodazole induce cell differentiation in rat neural cells and in Caco-2
cells, respectively, during the G2/M phase [38,39]. Moreover, human embryonic stem cells in the early
stages of endomesodermal differentiation require a pause in the G2 phase of the cell cycle [40].
In our experimental model, we found that the transcriptional remodeling of AD-MSCs in response
to the reprogramming cocktail is strictly related to the block of the cell cycle at the G2/M phase and
totally independent from extracellular Mg availability.
Then, since (i) low extracellular Mg induces the synthesis of ROS in various cell types [41],
and (ii) treatment with low concentrations of H2O2 fortifies MSCs against oxidative damage [42],
we evaluated ROS production in AD- and BM-MSCs. We found an increased accumulation of ROS
only in BM-MSCs cultured in low vs. their controls in physiologic Mg. The different behavior of
AD- and BM-MSCs might be ascribed to the high anti-oxidant arsenal of AD-MSCs. Indeed, these
cells are used to accelerate wound healing because of their anti-oxidant effects [43]. In the case of
BM-MSCs, oxidative stress blunts osteoblast differentiation, but osteogenic differentiation is partly ROS
dependent. Indeed, regulated ROS production is increasingly recognized as fundamental in promoting
essential signaling pathways that regulate stem cell proliferation, survival and differentiation [44,45].
Appropriate levels of ROS are required for the homing of hematopoietic stem cells to the bone marrow
after transplantation [46]. Moreover, an increase of endogenous ROS regulates self-renewal and
neurogenesis of neural stem cells [47]. On these bases, we hypothesize that Mg deficiency reversibly
accelerates BM-MSC differentiation in osteoblasts, partly through a modest increase of ROS.
Most cells sense Mg deficiency as a stressful condition and, consequently, activate adaptative
responses [18]. As an example, endothelial cells cultured under Mg-deficient conditions upregulate
stress proteins and this event modulates the functions of the cells [41]. In the case of MSCs,
we hypothesize that the cells react to Mg deprivation, which might threaten their integrity, by
remodeling their transcription as an attempt to escape damage and to be ready for regeneration
upon return to physiologic conditions. More studies are necessary to understand the mechanisms
underlying the effects of Mg deficiency on stem cell differentiation. An interesting aspect to explore is
whether Mg deprivation impacts on exosomes’ release and profile. Indeed, exosomes, 30–100 nm lipid
vesicles that serve as important mediators of intercellular communication [48], have been shown to
regulate osteoblast differentiation [49]. To the best of our knowledge, there is only one report linking
low Mg to exosomes, showing that Mg deficiency reduces the release of exosomes from placental
microvascular endothelial cells [50].
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4. Materials and Methods
4.1. Isolation and Culture of Human Mesenchymal Stem Cells
According to the policies approved by the Institutional Review Boards for Human Studies local
ethical committees, all tissue samples were obtained after oral informed consent from all subjects and
all experiments were performed in accordance with relevant guidelines and regulations approved
by the Ethics Committee of the University of Bologna (prot. no. 31335-X/10, 22 July 2011). Human
subcutaneous adipose tissue samples were obtained from lipoaspiration procedures and processed
mechanically by using the Lipogems device, as previously described [51]. Lipogems product was
cultured, until the AD-MSCs began to adhere and grow on the flasks [52]. These cells were characterized
for the expression of specific surface markers (Table S1), and the potential to differentiate along the
adipogenic, chondrogenic, and osteogenic lineages was previously assayed [51]. AD-MSCs were
obtained from three female donors with an average age of 44.0 ± 7.2 years.
Cells were cultured in minimum essential medium–α modification (α-MEM, Lonza, Walkersville,
MD, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Euroclone, Milan, Italy),
1% penicillin/streptomycin solution (10,000 U/mL penicillin, 10,000 mg/L streptomycin, Euroclone),
2 mM L-glutamine (Lonza). To study the transcriptional remodeling of these cells, twenty-four hours
after seeding, they were cultured in absence (control medium, CM) or presence (reprogramming
medium, RM) [23] of a mixture containing 10–20 kDa hyaluronic (2 mg/mL, Lifecore Biomedical,
Chaska, MN, USA, cat. no. HA10K), butyric (5 mM, Sigma-Aldrich, St. Louis, MO, USA, cat. no. B5887)
and retinoic acid (1 µM, Sigma-Aldrich, cat. no. R2625). Mg-free minimum essential medium (MEM)
was purchased as customized medium (Invitrogen, Carlsbad, CA, USA) and supplemented with
MgCl2 (1 mM, Sigma-Aldrich, cat. no. M8266). In some experiments, the cells were cultured for 5 days
in Mg-deficient medium, and then MgCl2 was added to reach the physiologic concentration of 1 mM
for additional 5 days.
BM-MSCs were isolated from human bone marrow withdrawn from bilateral punctures of the
posterior iliac crests of three healthy male volunteers (age 35–45), after obtaining oral informed consent
from all the subjects, and tested for purity by flow cytometry at the Policlinico in Milan according to
institutional guidelines and regulations approved by the IRCCS Policlinico and Università degli Studi
di Milano [53]. These cells were characterized for surface markers (Table S1), and were demonstrated
to undergo osteogenic and adipogenic differentiation in response to specific stimuli [31]. BM-MSCs
were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Lonza) with 1000 mg/L glucose, 10%
FBS and 2 mM L-glutamine (CM).
In some experiments, BM-MSCs were cultured in the presence of N-acetylcysteine (NAC, 1 mM,
Sigma-Aldrich, cat. no. A7250). To induce osteogenic differentiation, BM-MSCs were seeded in 6-well or
96-well plates. Once the cells were confluent, an osteogenic induction cocktail was added to the medium
(osteogenic medium, OM). The osteogenic cocktail contains 2 × 10−8 M 1α,25-Dihydroxyvitamin D3,
10 mM β-glycerolphosphate and 0.05 mM ascorbic acid (Sigma-Aldrich) [31]. To investigate calcium
deposition by BM-MSCs, the cells were rinsed with PBS, fixed (70% ethanol, 1 h) and stained for 10
min with 2% Alizarin Red S (pH 4.2, Sigma-Aldrich) [31]. The experiment was repeated three times in
triplicate. Photographs were taken at 10×magnification. Alizarin Red S staining was released from
the cell matrix by incubation in 10% cetylpyridinium chloride in 10 mM sodium phosphate (pH 7.0),
for 15 min and the absorbance measured at 550 nm.
All the cells were maintained at 37 ◦C and 5% CO2 in a humidified atmosphere.
4.2. Gene Expression Analysis
After 5 and 10 days of treatment, total RNA was extracted using RNeasy Microkit
(Qiagen, Hilden, Germany), and 1 µg was reverse-transcribed into cDNA in a 21-µL reaction
volume with SuperScriptTM III Reverse Transcriptase (Life Technologies, Carlsbad, CA, USA).
Real-time PCR was performed as previously described [24,31]. The experiment was performed
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3 times in triplicate and each sample was run in triplicate. The average threshold cycle (Ct) values
were used for calculations. Obtained Ct values were normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) transcript levels. Relative quantification of mRNA expression was calculated
with the comparative Ct method using the “delta-delta method” for comparing relative expression
results between treatments [54]. The values of the transcripts were normalized with respect to their
untreated controls.
See Table S2 for AD-MSC primer sequences.
For BM-MSC Real-time PCR, TaqMan Gene Expression Assays (Life Technologies) were used:
Hs00231692_m1 (RUNX2), Hs01866874_s1 (OSX), Hs00164004_m1 (COL1A1), Hs01587814_g1 (BGLAP),
Hs99999905_m1 (GAPDH).
4.3. Cell Cycle Analysis
Human adipose-derived MSCs were detached with 0.1% trypsin, 0.02% EDTA, washed twice
in DPBS and centrifuged. The pellet was suspended in 0.01% nonidet P-40, 10 mg/mL RNase, 0.1%
sodium citrate and 50 µg/mL propidium iodide (PI), for 30 min at room temperature in the dark.
Propidium iodide fluorescence was analyzed using a Bryte HS flow cytometer (Bio-Rad, Hercules,
CA, USA) equipped with Hg lamp and analyzed with ModFit 4(Verity Software House, Topsham,
ME, USA) software.
4.4. Quantification of Total Cell Mg by Spectrofluorimetric Assay
Total Mg content was assessed on sonicated cell samples of AD-MSCs by the fluorescent dye
DCHQ5 as reported as previously described [55,56].
4.5. Reactive Oxygen Species Evaluation
Intracellular oxidative stress was quantified using 2′-7′-dichlorofluorescein diacetate
(DCFH, Sigma-Aldrich, cat. no. 35845). Cells were seeded into black bottomed 96-well plates
(Greiner bio-one, Frickenhausen, Germany), cultured in medium containing 1 mM Mg or in
Mg-deficient medium. Some samples were treated with NAC 1 mM for 24 h. The cells were then
washed with PBS and exposed to DCFH (20 µM). The rate of intracellular oxidative stress was
evaluated by monitoring the emission at 529 nm of the DCFH dye using GloMax®-Multi Detection
System (Promega, Madison, WI, USA). Three independent experiments were performed. Data are
shown as the mean ± standard deviation.
4.6. Statistical Analysis
Differences of each experimental condition were evaluated by Student’s t test and set as follows:
* p < 0.05, ** p <0.01, *** p < 0.001.
5. Conclusions
These results offer new perspectives in stem cell research and in regenerative medicine showing
that Mg withdrawal could be exploited as a potentiating tool to enhance cell reprogramming
and differentiation.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/5/
1410/s1.
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Abbreviations
AD-MSCs Adipose-Derived Mesenchymal Stem Cells
BM-MSCs Bone Marrow Mesenchymal Stem Cells
NANOG Nanog Homeobox
GATA-4 GATA Binding Protein 4
NKX-2.5 NKX2 Homeobox 5
HGF Hepatocyte Growth Factor
KDR Kinase Insert Domain Receptor
NEUROG Neurogenin
ROS Reactive Oxygen Species
OSX Osterix
NAC N-acetylcysteine
CM Control Medium
RM Reprogramming Medium
OM Osteogenic Medium
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase
PI Propidium Iodide
DCFH 2′-7′-Dichlorofluorescein Diacetate
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